Ceftiofur
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Ceftiofur(F05965) |
| 2D Structure | |
| FRCD ID | F05965 |
| CAS Number | 80370-57-6 |
| PubChem CID | 6328657 |
| Formula | C19H17N5O7S3 |
| IUPAC Name | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| InChI Key | ZBHXIWJRIFEVQY-IHMPYVIRSA-N |
| InChI | InChI=1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1 |
| Canonical SMILES | CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O |
| Isomeric SMILES | CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O |
| Synonyms |
UNII-83JL932I1C
Ceftiofur Hydrochloride [USAN]
Ceftiofur
80370-57-6
Excenel
Ceftiofur hydrochloride
Ceftiofurum
83JL932I1C
Ceftiofur (INN)
C19H17N5O7S3.HCl
|
| Classifies |
Veterinary Drug
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Organoheterocyclic compounds |
| Class | Lactams |
| Subclass | Beta lactams |
| Intermediate Tree Nodes | Cephems |
| Direct Parent | Cephalosporins |
| Alternative Parents |
|
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Cephalosporin - N-acyl-alpha amino acid or derivatives - Alpha-amino acid or derivatives - Furoic acid or derivatives - 2,4-disubstituted 1,3-thiazole - Meta-thiazine - 1,3-thiazol-2-amine - Azole - Furan - Heteroaromatic compound - Tertiary carboxylic acid amide - Thiazole - Amino acid or derivatives - Azetidine - Carboxamide group - Amino acid - Secondary carboxylic acid amide - Carbothioic s-ester - Thiocarboxylic acid ester - Dialkylthioether - Sulfenyl compound - Hemithioaminal - Thioether - Thiocarboxylic acid or derivatives - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Oxacycle - Azacycle - Organic oxygen compound - Amine - Hydrocarbon derivative - Organic oxide - Carbonyl group - Organonitrogen compound - Organooxygen compound - Organosulfur compound - Primary amine - Organic nitrogen compound - Organopnictogen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as cephalosporins. These are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid moiety or a derivative thereof. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 523.553 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 9 |
| Complexity | 945 |
| Monoisotopic Mass | 523.029 |
| Exact Mass | 523.029 |
| XLogP | 0.2 |
| Formal Charge | 0 |
| Heavy Atom Count | 34 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.9878 |
| Human Intestinal Absorption | HIA- | 0.5082 |
| Caco-2 Permeability | Caco2- | 0.7558 |
| P-glycoprotein Substrate | Substrate | 0.6906 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8663 |
| Non-inhibitor | 0.6473 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8558 |
| Distribution | ||
| Subcellular localization | Plasma membrane | 0.3490 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8599 |
| CYP450 2D6 Substrate | Non-substrate | 0.8235 |
| CYP450 3A4 Substrate | Substrate | 0.5116 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7839 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7864 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8856 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7604 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7138 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8066 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9798 |
| Non-inhibitor | 0.8522 | |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.8700 |
| Fish Toxicity | High FHMT | 0.8678 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9406 |
| Honey Bee Toxicity | Low HBT | 0.6200 |
| Biodegradation | Not ready biodegradable | 0.9930 |
| Acute Oral Toxicity | IV | 0.5369 |
| Carcinogenicity (Three-class) | Non-required | 0.4771 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -2.6947 | LogS |
| Caco-2 Permeability | -0.2154 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 1.6899 | LD50, mol/kg |
| Fish Toxicity | 1.3107 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.5404 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Milk | Japan | 0.1ppm | |||
| Pig,Kidney | Japan | 6.0ppm | |||
| Milk Of Cattle | United States | 0.1ppm | |||
| Muscle Of Cattle | United States | 1ppm | |||
| Liver Of Cattle | United States | 2ppm | |||
| Kidney Of Cattle | United States | 0.4ppm | |||
| Muscle Of Swine | United States | 2ppm | |||
| Liver Of Swine | United States | 3ppm | |||
| Kidney Of Swine | United States | 0.25ppm | |||
| Edible Tissues Of Sheep | United States | 0.t required | |||
| Edible Tissues Of Poultry | United States | 0.t required | |||
| Other Terrestrial Mammals,Edible Offal | Japan | 2ppm | |||
| Pig,Edible Offal | Japan | 2ppm | |||
| Cattle,Edible Offal | Japan | 2ppm | |||
| Other Terrestrial Mammals,Liver | Japan | 2ppm | |||
| Other Terrestrial Mammals,Fat | Japan | 2ppm | |||
| Other Terrestrial Mammals,Muscle | Japan | 1ppm | |||
| Cattle,Kidney | Japan | 6.0ppm | |||
| Pig,Liver | Japan | 2. oppm | |||
| Cattle,Liver | Japan | 2. oppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Comparative Study on Antibiotic Resistance and DNA Profiles of Salmonellaenterica Serovar Typhimurium Isolated from Humans, Retail Foods, and theEnvironment in Shanghai, China. | Foodborne Pathog Dis | 2018 May 9 | 29741928 |
| Validation of the BetaStar® Advanced for Beta-lactams Test Kit for the Screening of Bulk Tank and Tanker Truck Milks for the Presence of Beta-lactam DrugResidues. | J AOAC Int | 2018 May 18 | 29776460 |
| Changes in feeding, social, and lying behaviors in dairy cows with metritisfollowing treatment with a nonsteroidal anti-inflammatory drug as adjunctivetreatment to an antimicrobial. | J Dairy Sci | 2018 May | 29477521 |
| Prevalence of Salmonella enterica, Listeria monocytogenes, and pathogenicEscherichia coli in bulk tank milk and milk filters from US dairy operations inthe National Animal Health Monitoring System Dairy 2014 study. | J Dairy Sci | 2018 Mar | 29274964 |
| Decrease in the prevalence of extended-spectrum cephalosporin-resistantSalmonella following cessation of ceftiofur use by the Japanese poultry industry. | Int J Food Microbiol | 2018 Jun 2 | 29626788 |
| Effects of Ceftiofur and Chlortetracycline on the Resistomes of Feedlot Cattle. | Appl Environ Microbiol | 2018 Jun 18 | 29728379 |
| High prevalence of ESBLs in retail chicken meat despite reduced use ofantimicrobials in chicken production, France. | Int J Food Microbiol | 2017 Sep 18 | 28728058 |
| Prevalence and antimicrobial susceptibility of Mannheimia haemolytica,Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratorydisease. | Vet Microbiol | 2017 Sep | 28888626 |
| Effect of ceftiofur and enrofloxacin on E. coli sub-population in piggastrointestinal tract. | J Glob Antimicrob Resist | 2017 Sep | 28732789 |
| Population dynamics of enteric Salmonella in response to antimicrobial use inbeef feedlot cattle. | Sci Rep | 2017 Oct 30 | 29085049 |
| Effects of feeding pasteurized waste milk to dairy calves on phenotypes andgenotypes of antimicrobial resistance in fecal Escherichia coli isolates beforeand after weaning. | J Dairy Sci | 2017 Oct | 28755935 |
| Elimination kinetics of ceftiofur hydrochloride in milk after an 8-day extendedintramammary administration in healthy and infected cows. | PLoS One | 2017 Nov 2 | 29095869 |
| Surveillance of antimicrobial resistance among Escherichia coli from chicken and swine, China, 2008-2015. | Vet Microbiol | 2017 May | 28619166 |
| Determinants of virulence and of resistance to ceftiofur, gentamicin, andspectinomycin in clinical Escherichia coli from broiler chickens in Québec,Canada. | Vet Microbiol | 2017 May | 28619137 |
| A Whole-Genome Sequencing Approach To Study Cefoxitin-Resistant Salmonellaenterica Serovar Heidelberg Isolates from Various Sources. | Antimicrob Agents Chemother | 2017 Mar 24 | 28137797 |
| Isolation and characterization of Avibacterium paragallinarum with differentnicotinamide adenine dinucleotide requirements. | Vet Microbiol | 2017 Jun | 28622864 |
| Normal milk microbiome is reestablished following experimental infection withEscherichia coli independent of intramammary antibiotic treatment with athird-generation cephalosporin in bovines. | Microbiome | 2017 Jul 12 | 28701174 |
| Models of antimicrobial pressure on intestinal bacteria of the treated hostpopulations. | Epidemiol Infect | 2017 Jul | 28462738 |
| Carbapenemase-Producing Enterobacteriaceae Recovered from the Environment of aSwine Farrow-to-Finish Operation in the United States. | Antimicrob Agents Chemother | 2017 Jan 24 | 27919894 |
| Prevalence and antimicrobial resistance of Salmonella isolated from two porkprocessing plants in Alberta, Canada. | Int J Food Microbiol | 2017 Jan 16 | 27750110 |